IGF1R and neoplasm: Insulin, through the binding to its receptor or to the insulin-like growth factor receptor (IGFR), activates the mTOR, PI3K, and MAPK pathways [87], inhibits apoptosis, and stimulates tumor proliferation and angiogenesis [88,89].